Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > News > UK small caps open easier

October 11th, 2006

UK small caps open easier

Abstract:
Alltracel Pharmaceuticals hardened 1/2 to 10-1/2 following Q3 results showing revenues up 10 pct at 5.5 mln eur and after news of the launch of NANOPEUTICS, the nanotechnology JV for the global woundcare market.

Source:
lse.co.uk

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Alltracel Pharmaceuticals

Related News Press

Announcements

Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013

International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013

Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013

Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013

Financial Reports

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE